Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Vermont

15 recruiting clinical trials across 4 cities in Vermont (VT). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
15
Total Trials
15
Recruiting Now
4
Cities
20
Conditions

Recruiting Trials in Vermont

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGPhase 1NCT04294043

IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)

The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NTM. Funding Source...

Sponsor: Chris GossEnrolling: 4010 locations
Nontuberculous Mycobacterium Infection
RECRUITINGNCT05080998

Longitudinal Bladder Cancer Study for Tumour Recurrence

Surveillance for recurrence of urothelial carcinoma (UC) requires frequent cystoscopy, which is invasive, expensive and time-consuming. An accurate urinary biomarker has the...

Sponsor: Pacific Edge LimitedEnrolling: 4507 locations
Urothelial Bladder Cancer
RECRUITINGNCT05302375

Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)

The purpose of this study is to determine the extent to which an online pathway to depression treatment (iPath\*D) is acceptable and usable to patients receiving cancer treatment...

Sponsor: Dartmouth-Hitchcock Medical CenterEnrolling: 301 location
CancerDepression
RECRUITINGPhase 3NCT05422222

Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age

The purpose of this study is to evaluate the pharmacokinetics, safety, tolerability and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in CF participants with at...

Sponsor: Vertex Pharmaceuticals IncorporatedEnrolling: 21020 locations
Cystic Fibrosis
RECRUITINGPhase 3NCT05509777

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Study participants will be screened during the platform study and randomly assigned to receive mirikizumab or another intervention. The purpose of the mirikizumab study is to...

Sponsor: Eli Lilly and CompanyEnrolling: 9020 locations
Crohn's Disease
RECRUITINGPhase 2 / Phase 3NCT05637879

Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder

A double-blind randomized placebo-controlled trial to further investigate glecaprevir/pibrentasvir (GLE/PIB), a direct acting antiviral (DAA) that has been associated with...

Sponsor: White River Junction Veterans Affairs Medical CenterEnrolling: 921 location
PTSD
RECRUITINGPhase 1NCT06154447

Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis

The purpose of the study is to evaluate safety, tolerability, and pharmacokinetics of VX-828 and VX-828 in triple combination (TC) with Tezacaftor (TEZ)/ VX-118 or TEZ/...

Sponsor: Vertex Pharmaceuticals IncorporatedEnrolling: 25511 locations
Cystic Fibrosis
RECRUITINGNCT06191640

Sinus Disease in Young Children With Cystic Fibrosis

This is a prospective, observational study examining the impact of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators on chronic rhinosinusitis...

Sponsor: University of California, Los AngelesEnrolling: 806 locations
Cystic Fibrosis in ChildrenCystic FibrosisChronic Rhinosinusitis (Diagnosis)+2
RECRUITINGNCT06432972

Accelerated Pulmonary Rehabilitation in the Preoperative Period

This proposed project will be a single arm, non-masked study. Participants who are actively smoking with a diagnosis of a new lung nodule, either confirmed or suspicious for lung...

Sponsor: University of VermontEnrolling: 201 location
Chronic Obstructive Pulmonary DiseaseLung Cancer
RECRUITINGPhase 3NCT06463587

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized...

The purpose of this clinical study is to determine the efficacy and safety of a new oral cladribine formulation in participants with Generalized Myasthenia Gravis (gMG) in...

Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyEnrolling: 26420 locations
Generalized Myasthenia Gravis
RECRUITINGNCT06529978

Endocardial Mapping With the CoreMap EP Mapping System

This is a global, multi-site, prospective, feasibility study.

Sponsor: CoreMap INC.Enrolling: 2453 locations
Persistent Atrial Fibrillation
RECRUITINGPhase 2NCT06614504

Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes

Cigarette smoking remains the leading cause of preventable morbidity and mortality in the US. Use of multiple tobacco products is becoming increasingly prevalent, with dual use of...

Sponsor: University of VermontEnrolling: 3082 locations
Tobacco Use Disorder
RECRUITINGNCT06678841

ELEVATE-HFpEF Clinical Study

ELEVATE-HFpEF is a prospective, randomized, controlled, double-blinded, multi-center, global, interventional pivotal study evaluating the safety and efficacy of dual chamber...

Sponsor: Medtronic Cardiac Rhythm and Heart FailureEnrolling: 70020 locations
Heart Failure With Preserved Ejection Fraction (HFpEF)
RECRUITINGPhase 2NCT06972875

Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer

This study is for men with prostate cancer who are experiencing hot flashes due to treatments that lower testosterone. Hot flashes can affect your quality of life and make it...

Sponsor: University of VermontEnrolling: 321 location
Prostate CAAndrogen Deprivation Therapy
RECRUITINGNCT07336251

Transcranial Magnetic Stimulation in Veterans With PTSD

With this research investigators hope to begin to understand how rTMS can improve posttraumatic stress disorder (PTSD) symptoms. TMS improves PTSD through two interrelated...

Sponsor: White River Junction Veterans Affairs Medical CenterEnrolling: 201 location
PTSD - Post Traumatic Stress Disorder

Browse Trials by State

Frequently Asked Questions

There are currently 15 clinical trials actively recruiting participants in Vermont. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in Vermont include Cystic Fibrosis, Nontuberculous Mycobacterium Infection, Urothelial Bladder Cancer, Cancer, Depression. Each has multiple active trials across research centers in the state.

Major trial sites in Vermont include Burlington, White River Junction, Colchester, Saint Johnsbury. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.